MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2

Molecular Oncology

Volumn 8, Issue 3, 2014, Pages 581-595

  Kronski, Emanuel ^a   Fiori, Micol E ^b   Barbieri, Ottavia ^c,d   Astigiano, Simonetta ^c   Mirisola, Valentina ^d   Killian, Peter H ^a   Bruno, Antonino ^e   Pagani, Arianna ^e   Rovera, Francesca ^f   Pfeffer, Ulrich ^d   Sommerhoff, Christian P ^a   Noonan, Douglas M ^e,f   Nerlich, Andreas G ^g   Fontana, Laura ^b,h   Bachmeier, Beatrice E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e IRCCS MULTIMEDICA   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g KLINIKUM BOGENHAUSEN   (Germany)

^h ZappyLab   (United States)

Author keywords

Breast cancer; Curcumin; Inflammatory cytokines; Metastases prevention; MicroRNAs

Indexed keywords

CURCUMIN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; MICRORNA; MICRORNA 181B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN181 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER METASTASIS; BREAST METASTASIS; CANCER CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BREAST; BREAST NEOPLASMS; DOWN REGULATION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; NEOPLASM METASTASIS; PATHOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE; UPREGULATION;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CURCUMIN; DOWN-REGULATION; FEMALE; HUMANS; MICE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84899152610     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.01.005     Document Type: Article

References (58)

1. Albini, A., Indraccolo, S., Noonan, D.M., Pfeffer, U., Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clin. Exp. Metastasis 27, 419-439.
2. Albini A., Mirisola V., Pfeffer U. Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev. 2008, 27:75-83.
3. Albini A., Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat.Rev. Cancer 2007, 7:139-147.
4. Albini A., Tosetti F., Benelli R., Noonan D.M. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res. 2005, 65:10637-10641.
5. Albini A., Tosetti F., Li V.W., Noonan D.M., Li W.W. Cancer prevention by targeting angiogenesis. Nat. Rev. Clin. Oncol. 2012, 9:498-509.
6. Alvarez, R.H., Present and future evolution of advanced breast cancer therapy. Breast Cancer Res. 12 Suppl 2, S1.
7. Bachmeier B., Nerlich A.G., Iancu C.M., Cilli M., Schleicher E., Vene R., Dell'Eva R., Jochum M., Albini A., Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol. Biochem 2007, 19:137-152.
8. Bachmeier B.E., Iancu C.M., Killian P.H., Kronski E., Mirisola V., Angelini G., Jochum M., Nerlich A.G., Pfeffer U. Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol. Cancer 2009, 8:129.
9. Bachmeier B.E., Killian P., Pfeffer U., Nerlich A.G. Novel aspects for the application of Curcumin in chemoprevention of various cancers. Front. Biosci. 2010, 2:697-717.
10. Bachmeier B.E., Mirisola V., Romeo F., Generoso L., Esposito A., Dell'eva R., Blengio F., Killian P.H., Albini A., Pfeffer U. Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin. Cell Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2010, 26:471-482.
11. Bachmeier B.E., Mohrenz I.V., Mirisola V., Schleicher E., Romeo F., Hohneke C., Jochum M., Nerlich A.G., Pfeffer U. Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis 2008, 29:779-789.
12. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357:539-545.
13. Bierie B., Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 2006, 6:506-520.
14. Bissell M.J., Hines W.C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 2011, 17:320-329.
15. Bisso, A., Faleschini, M., Zampa, F., Capaci, V., De Santa, J., Santarpia, L., Piazza, S., Cappelletti, V., Daidone, M., Agami, R., Del Sal, G., Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle 12, 1679-1687.
16. Bruno, A., Focaccetti, C., Pagani, A., Imperatori, A.S., Spagnoletti, M., Rotolo, N., Cantelmo, A.R., Franzi, F., Capella, C., Ferlazzo, G., Mortara, L., Albini, A., Noonan, D.M., The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer. Neoplasia 15, 133-142.
17. de Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 2006, 6:24-37.
18. DeNardo D.G., Andreu P., Coussens L.M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010, 29:309-316.
19. Dhillon N., Aggarwal B.B., Newman R.A., Wolff R.A., Kunnumakkara A.B., Abbruzzese J.L., Ng C.S., Badmaev V., Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 2008, 14:4491-4499.
20. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., Boldrini R., Donfrancesco A., Federici V., Giacomini P., Peschle C., Fruci D. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 2008, 3:e2236.
21. Fontana L., Pelosi E., Greco P., Racanicchi S., Testa U., Liuzzi F., Croce C.M., Brunetti E., Grignani F., Peschle C. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 2007, 9:775-787.
22. Gandhy, S.U., Kim, K., Larsen, L., Rosengren, R.J., Safe, S., Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer 12, 564.
23. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A.J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J.Y., Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5:R80.
24. Gupta S.C., Kim J.H., Prasad S., Aggarwal B.B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010, 29:405-434.
25. Halpern, J.L., Kilbarger, A., Lynch, C.C., Mesenchymal stem cells promote mammary cancer cell migration invitro via the CXCR2 receptor. Cancer Lett. 308, 91-99.
26. Hurst D.R., Edmonds M.D., Welch D.R. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res. 2009, 69:7495-7498.
27. Irvin, W., Jr., Muss, H.B., Mayer, D.K., Symptom management in metastatic breast cancer. Oncologist 16, 1203-1214.
28. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
29. Killian P.H., Kronski E., Michalik K.M., Barbieri O., Astigiano S., Sommerhoff C.P., Pfeffer U., Nerlich A.G., Bachmeier B.E. Curcumin inhibits prostate cancer metastasis invivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis 2012, 33:2507-2519.
30. Kong Y.W., Ferland-McCollough D., Jackson T.J., Bushell M. microRNAs in cancer management. Lancet Oncol. 2012, 13:e249-258.
31. Krol, J., Loedige, I., Filipowicz, W., The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610.
32. Lujambio A., Lowe S.W. The microcosmos of cancer. Nature 2012, 482:347-355.
33. Madden, S.F., Clarke, C., Gaule, P., Aherne, S.T., O'Donovan, N., Clynes, M., Crown, J., Gallagher, W.M., BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer Outcome. Breast Cancer Res. 15, R52.
34. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 2010, 22:231-237.
35. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
36. Neelakandan, K., Babu, P., Nair, S., Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Curr. Cancer Drug Targets 12, 716-740.
37. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
38. Noonan D.M., De Lerma Barbaro A., Vannini N., Mortara L., Albini A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev. 2008, 27:31-40.
39. Noonan D.M., Sogno I., Albini A. Plants and plant-derived products as cancer chemopreventive agents. Herbal Medicines: Development and Validation of Plant-derived Medicines for Human Health 2011, 285-306. CRC Press Inc, ISBN-10: 1439837686 ISBN-13: 9781439837689. G. Bagetta, M. Cosentino, M.T. Corasaniti, S. Sakurada (Eds.).
40. Olarerin-George, A.O., Anton, L., Hwang, Y.C., Elovitz, M.A., Hogenesch, J.B., A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC Biol. 11, 19.
41. Peinado H., Rafii S., Lyden D. Inflammation joins the "niche". Cancer Cell 2008, 14:347-349.
42. Pfeffer U. Cancer Genomics: Molecular Classification, Prognosis and Response Prediction 2013, Springer Science and Business Media, Dordrecht.
43. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 2009, 9:285-293.
44. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 2003, 33:49-54.
45. Reuter S., Gupta S.C., Park B., Goel A., Aggarwal B.B. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011, 6:93-108.
46. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
47. Seoudi, A.M., Lashine, Y.A., Abdelaziz, A.I., MicroRNA-181a - a tale of discrepancies. Expert Rev Mol Med 14, e5.
48. Shoushtari A.N., Szmulewitz R.Z., Rinker-Schaeffer C.W. Metastasis-suppressor genes in clinical practice: lost in translation?. Nat. Rev. Clin. Oncol. 2011, 8:333-342.
49. Sporn, M.B., Perspective: the big C - for Chemoprevention. Nature 471, S10-S11.
50. Sreenivasan, S., Thirumalai, K., Danda, R., Krishnakumar, S., Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. Curr. Eye Res. 37, 421-428.
51. Subramaniam, D., Ponnurangam, S., Ramamoorthy, P., Standing, D., Battafarano, R.J., Anant, S., Sharma, P., Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS ONE 7, e30590.
52. Sun M., Estrov Z., Ji Y., Coombes K.R., Harris D.H., Kurzrock R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7:464-473.
53. Sun, X., Icli, B., Wara, A.K., Belkin, N., He, S., Kobzik, L., Hunninghake, G.M., Vera, M.P., Blackwell, T.S., Baron, R.M., Feinberg, M.W., MicroRNA-181b regulates NF-kappaB-mediated vascular inflammation. J. Clin. Invest 122, 1973-1990.
54. Taylor, M.A., Sossey-Alaoui, K., Thompson, C.L., Danielpour, D., Schiemann, W.P., TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J. Clin. Invest 123, 150-163.
55. White N.M., Fatoohi E., Metias M., Jung K., Stephan C., Yousef G.M. Metastamirs: a stepping stone towards improved cancer management. Nat. Rev. Clin. Oncol. 2011, 8:75-84.
56. Xu, J., Zhang, C., He, Y., Wu, H., Wang, Z., Song, W., Li, W., He, W., Cai, S., Zhan, W., Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int. J. Cancer 130, 787-797.
57. Yang J., Cao Y., Sun J., Zhang Y. Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med Oncol 2010 Dec, 27(4):1114-1118. Epub 2009 Nov 12. 10.1007/s12032-009-9344-3.
58. Zhang R.D., Fidler I.J., Price J.E. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis 1991, 11:204-215.